Status:

COMPLETED

Double-Blind 2-Site Randomized Clinical Trial of Neurofeedback for ADHD

Lead Sponsor:

Ohio State University

Collaborating Sponsors:

National Institute of Mental Health (NIMH)

University of North Carolina

Conditions:

Attention-Deficit/Hyperactivity Disorder

Eligibility:

All Genders

7-10 years

Phase:

NA

Brief Summary

Additional treatments with long-term benefit for attention-deficit/hyperactivity disorder (ADHD) are needed; one of the more promising is neurofeedback (EEG biofeedback), which has several randomized ...

Detailed Description

Current established, evidence-based treatments for attention-deficit/hyperactivity disorder (ADHD) are incompletely effective and not universally acceptable, and appear to wane in effect over time des...

Eligibility Criteria

Inclusion

  • Boys and girls age 7 to 10
  • IQ\>80
  • diagnosed DSM-5 ADHD inattentive presentation or combined presentation
  • an item mean ≥1.5 sd above norms on a 0-3 metric both on parent ratings of either DSM-IV inattentive symptoms or all 18 ADHD symptoms and on teacher ratings of either inattentive symptoms or all 18 ADHD symptoms
  • an eyes-open QEEG with theta-beta power ratio \>4.5 at Cz or Fz

Exclusion

  • comorbid disorder requiring psychoactive medication other than FDA-approved ADHD medication
  • a medical disorder requiring systemic chronic medication with confounding psychoactive effects
  • sleep apnea
  • restless legs syndrome
  • IQ \<80
  • plans to move requiring school change during the next 3 months
  • plans to start other ADHD treatment in the next 3 months
  • antipsychotic agent in the 6 months prior to baseline assessment
  • fluoxetine in the 4 weeks prior to baseline
  • other psychiatric medication in the two weeks prior to baseline
  • \>5 previous NF treatments
  • Vitamin D deficiency will be a temporary exclusion

Key Trial Info

Start Date :

September 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2020

Estimated Enrollment :

144 Patients enrolled

Trial Details

Trial ID

NCT02251743

Start Date

September 1 2014

End Date

August 1 2020

Last Update

September 29 2020

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University of North Carolina at Asheville

Asheville, North Carolina, United States, 28804

2

The Ohio State University Nisonger Center

Columbus, Ohio, United States, 43215

Double-Blind 2-Site Randomized Clinical Trial of Neurofeedback for ADHD | DecenTrialz